This is the question a trial beginning in the UK hopes to answer. The randomised controlled study will test the hypothesis that the onset of arthritis in an ‘at risk’ group can be prevented or delayed by a biologic. To be included in the Arthritis Prevention In the Pre-clinical Phase of Rheumatoid Arthritis with Abatacept (APIPPRA) patients will have ...
Is it possible to delay RA?
8 Apr 2015